Table 2.

Oxytocin Side-Effects among Women receiving Low Rate and High Rate Oxytocin Infusions.

Time after commencing study infusion*
	2 min	4 min	6 min	8 min	10 min	12 min	14 min	16 min	18 min	20 min
Nausea
Low Rate Infusion	3 (12.5%)	3 (12.5%)	1 (4.2%)	1 (4.2%)	1 (4.2%)	1 (4.2%)	4 (16.7%)	3 (12.5%)	2 (8.3%)	2 (8.3%)
High Rate Infusion	1 (3.7%)	1 (3.7%)	0	0	1 (3.7%)	1 (3.7%)	1 (3.7%)	0	0	1 (3.7%)
Dyspnea
Low Rate Infusion	0	0	0	0	0	0	1 (4.2%)	0	1 (4.2%)	1 (4.2%)
High Rate Infusion	0	0	0	0	0	0	0	0	0	0
Flushing
Low Rate Infusion	2 (8.3%)	3 (12.5%)	3 (12.5%)	3 (12.5%)	3 (12.5%)	4 (16.7%)	4 (16.7%)	2 (8.3%)	2 (8.3%)	2 (8.3%)
High Rate Infusion	1 (3.7%)	0	0	0	0	0	0	0	0	0
Headache
Low Rate Infusion	0	0	0	0	0	0	1 (4.2%)	1 (4.2%)	2 (8.3%)	2 (8.3%)
High Rate Infusion	0	0	0	0	1 (3.7%)	1 (3.7%)	0	0	1 (3.7%)	1 (3.7%)
Chest Pain
Low Rate Infusion	1 (4.2%)	2 (8.3%)	2 (8.3%)	2 (8.3%)	2 (8.3%)	1 (4.2%)	2 (8.3%)	1 (4.2%)	1 (4.2%)	1 (4.2%)
High Rate Infusion	2 (7.4%)	2 (7.4%)	2 (7.4%)	2 (7.4%)	2 (7.4%)	1 (7.4%)	1 (3.7%)	2 (7.4%)	2 (7.4%)	3 (11.1%)
Tachycardia
Low Rate Infusion	1 (4.2%)	0	0	0	0	0	0	0	0	0
High Rate Infusion	0	0	0	0	0	1 (3.7%)	1 (3.7%)	0	0	0

Data presented as n (%).

^*Time represents the time-period that has elapsed after commencing the oxytocin maintenance infusion.